A Study to Evaluate the Intramuscular Administration of Scopolamine

Exclusion criteria

• . Received any other investigational drug within 30 days prior to drug administration
• . Known allergies to any component of the study drug, other belladonna alkaloids, or the recovery medications (physostigmine, atropine, or benzodiazepines \[diazepam or lorazepam\])
• . History of migraine headaches or seizures
• . History of psychosis or psychotic episodes
• . Clinically relevant abnormal physical findings (including vital signs) as determined by the investigator at screening or prior to drug administration that could interfere with the objectives of the study or the safety of the subject
• . Has ongoing drug abuse/dependence (including alcohol), recent history (over the past 5 years) of treatment for alcohol or drug abuse, or a current positive alcohol breathalyzer test or current positive urine test for drugs of abuse (as defined in Section 11.1.9.5) at screening or prior to drug administration
• . Has consumed Seville orange (bitter orange), grapefruit, grapefruit juice, other grapefruit-containing products, or starfruit within 7 days prior to dosing
• . Has consumed caffeine or other xanthine-containing products within 7 days prior to dosing